(Q54266875)

27 May 2018

title

RASSF1A in maternal plasma as a molecular marker of preeclampsia. (English)

1 reference

27 May 2018

0 references

Aspasia Destouni

5

0 references

author name string

Nikolas Papantoniou

1

1 reference

27 May 2018

Vassilis Bagiokos

2

1 reference

27 May 2018

Kostantinos Agiannitopoulos

3

1 reference

27 May 2018

Aggeliki Kolialexi

4

1 reference

27 May 2018

Georgia Tounta

6

1 reference

27 May 2018

Emmanuel Kanavakis

7

1 reference

27 May 2018

Aris Antsaklis

8

1 reference

27 May 2018

Ariadni Mavrou

9

1 reference

27 May 2018

publication date

22 March 2013

1 reference

27 May 2018

published in

Prenatal Diagnosis

1 reference

27 May 2018

volume

33

1 reference

27 May 2018

issue

7

1 reference

27 May 2018

page(s)

682-687

1 reference

27 May 2018

Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome

cites work

1 reference

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

21 January 2018

1 reference

Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG

21 January 2018

1 reference

First-trimester prediction of hypertensive disorders in pregnancy.

21 January 2018

1 reference

Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood.

21 January 2018

1 reference

PLAC4 is upregulated in severe early onset preeclampsia and upregulated with syncytialisation but not hypoxia

21 January 2018

1 reference

THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIA

21 January 2018

1 reference

Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.

21 January 2018

1 reference

Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency

21 January 2018

1 reference

Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.

21 January 2018

1 reference

Refined fluorescent STR quantification of cell-free fetal DNA during pregnancy in physiological and Down syndrome fetuses.

21 January 2018

1 reference

Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.

21 January 2018

1 reference

Hypermethylation of RASSF1A in human and rhesus placentas

21 January 2018

1 reference

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

21 January 2018

1 reference

Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies.

21 January 2018

1 reference

Can detection of late-onset PE at triage by sflt-1 or PlGF be improved by the use of additional biomarkers?

21 January 2018

1 reference

Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia

21 January 2018

1 reference

Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield

21 January 2018

1 reference

Disturbed feto-maternal cell traffic in preeclampsia.

21 January 2018

1 reference

A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.

21 January 2018

1 reference

Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.

21 January 2018

1 reference

Presence of fetal DNA in maternal plasma and serum

21 January 2018

1 reference

Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PD.4093

1 reference

27 May 2018

1 reference

27 May 2018